Neutropenic bacteraemia - Microbiology and empiric antibiotic treatment;Bakteriemi ved granulocytopeni - Mikrobiologi og empirisk antibiotikabehandling

Tidsskrift for den Norske Laegeforening

Volumn 118, Issue 28, 1998, Pages 4370-4375

  Hammerstrøm, Jens ^a   Jacobsen, Trond ^b  

^a Hematologisk Seksjon   (Norway)

^b Avdeling for Mikrobiologi   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; IMIPENEM; PENICILLIN DERIVATIVE; VANCOMYCIN;

ACUTE LEUKEMIA; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; DRUG MIXTURE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NEUTROPENIA; NORWAY; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA; TEACHING HOSPITAL;

AGRANULOCYTOSIS; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; FEVER; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; PENICILLIN RESISTANCE; PENICILLINS; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0032553405     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328: 1323-2.
2. Bodey GP. Empirical antibiotic therapy for fever in neutropenic patients. Clin Infect Dis 1993; 17 (suppl 2): 378-4.
3. Hughes WT, Armstrong D, Bodey GP, Feld R, Mandell GL, Meyers JD et al. Guidelines for the use of antimicrobial agents in neutropenic patients with fever. J Infect Dis 1990; 161: 381-96.
4. The EORTC international antimicrobial therapy project group. Three antibiotic regimes in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 1978; 137: 14-29.
5. Wade JC. Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs monotherapy. Rev Infect Dis 1989; 11 (suppl 7): 1572-81.
6. Norrby SR, Vandercam B, Louie T, Runde V, Norberg B, Anniko M et al. Imipenem/Cilastatin versus Amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study. Scand J Infect Dis Suppl 1987; 52: 65-78.
7. De Pauw BE, Deresinsky SC, Feld R, Lane-Allman EF, Donnelly JP. Ceftazidim compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. Ann Intern Med 1994; 120: 834-44.
8. Koll BS, Brown AE. The changing epidemiology of infections at cancer hospitals. Clin Infect Dis 1993; 17 (suppl 2): 322-8.
9. Kern W, Kurrle E, Schmeiser T. Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases. Infection 1990; 18: 38-45.
10. Bodey GP, Jadeja L, Biting L. Pseudomonas bacteremia: retrospective analysis of 410 episodes. Arch Intern Med 1985; 145: 1621-9.
11. De Jongh CA, Joshi JH, Newman KA, Moody MR, Wharton R, Standiford HC et al. Antibiotic synergism and response in gram-negative bacteremia in granulocytopenic patients. Am J Med 1986; 80 (suppl 5C): 96-100.
12. Ehni WF, Reller LB, Ellison RT. Bacteremia in granulocytic patients in a tertiary-care general hospital. Rev Infect Dis 1991; 13: 613-9.
13. Midtvedt T. Mikrobebiologi og økologi - mikrobeaspektet. Tidsskr Nor Lægeforen 1995; 115: 2896-8.
14. Haug JB, Harthug S, Kalager T, Digranes A, Solberg CO. Bloodstream infections at a Norwegian University Hospital, 1974-1979 and 1988-1989: changing etiology, clinical features and outcome. Clin Infect Dis 1994; 19: 246-56.
15. Dybedal I, Lamvik J. Respiratory insufficiency in acute leukemia following treatment with cytosine arabinoside and septicemia with Streptococcus viridans. Eur J Haematol 1989; 42: 405-6.
16. Elting LS, Khardori N, Bodey GP, Fainstein V. Nosocomial infection caused by Stenotrophomonas maltophilia: a case-control study of predisposing factors. Infect Control Hosp Epidemiol 1990; 11: 134-8.
17. Jacobson KL, Cohen SH, Inciardi JF, King JH, Lippert WE, Iglesias T et al. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms. Clin Infect Dis 1995; 21: 1107-13.
18. Verbist L. Epidemiology and sensitivity of 8625 ICU and hematology/oncology bacterial isolates in Europe. Scand J Infect Dis Suppl 1993; 91: 14-24.
19. Dornbusch K, Miller GH, Hare RS, Shaw KJ, and the ESGAR study group. Resistance to aminoglykoside antibiotics in Gram-negative bacilli and staphylococci isolated from blood. Report from a collaborative study. J Antimicrob Chemother 1990; 26: 131-44.
20. Svarva PL. Vancomycinresistente enterokokker påvist i Trondheim. MSIS-rapport 1995; 23: 49.